Home About Products Technology Investor Relations News Contact INVESTOR FAQ Where is CytoSorbents Corporation headquartered? CytoSorbents is headquartered in Monmouth Junction, New Jersey. When was CytoSorbents incorporated? CytoSorbents Corporation, formerly known as RenalTech or MedaSorb Technologies, was incorporated on 4/25/02. What is CytoSorbents’ address? 7 Deer Park Drive, Suite K Monmouth Junction, NJ 08852 Who can I contact for additional information regarding CytoSorbents? For Investor Inquiries, please contact: Terri Anne Powers CytoSorbents Investor Relations & Corporate Communications 732-482-9984 TPowers@cytosorbents.com For Media Inquiries, please contact: Eric Kim Rubenstein Public Relations 212.805.3052 ekim@rubensteinpr.com What exchange does CytoSorbents’ common stock trade and what is its ticker symbol? NASDAQ: CTSO Does CytoSorbents pay a dividend? No, the company does not pay a dividend. Does CytoSorbents have a Direct Stock Purchase Plan? No, the company does not have a Direct Stock Purchase Plan. Who is CytoSorbents’ transfer agent and how can I contact them? American Stock Transfer & Trust Company Shareholder Relations 6201 15th Avenue Brooklyn, NY 11219 800-937-5449 How do I get copies of financial documents such as Form 10-K or Form 10-Q? Our most recent filings may be found at www.sec.gov or www.nasdaq.com Privacy Information Data Protection Disclaimer Contact CytoSorbents is a leader in critical care immunotherapy. The company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders. Are you an Investor? CytoSorb® is a unique blood purification therapy.The product is currently approved in the European Union and distributed in 58 countries around the world Are you a Healthcare Provider?

Home About Products Technology Investor Relations News Contact ANALYST COVERAGE Firm Cowen & Co. SVB Leerink Jefferies H.C. Wainwright & Co B. Riley FBR Dawson James Analyst Joshua Jennings, MD Danielle Antalffy Anthony Petrone, MBA Sean Lee, CFA Andrew D’Silva Jason Kolbert, MBA CytoSorbents Corporation is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding CytoSorbents Corporation’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of CytoSorbents Corporation or its management. CytoSorbents Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Privacy Information Data Protection Disclaimer Contact CytoSorbents is a leader in critical care immunotherapy. The company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders. Are you an Investor? CytoSorb® is a unique blood purification therapy.The product is currently approved in the European Union and distributed in 58 countries around the world Are you a Healthcare Provider?